Proteologics
Latest round
- Series A
Last raised
- Mar 2001
Total raised
- $14M
Investors
- 3
About Proteologics
Proteologics is a digital asset management company headquartered in Rehovot, Israel. The company focuses on providing services around the staking of its native token, ADAO. In January 2010, Proteologics completed an IPO.com primarily offers a digital asset management platform focused on the staking of its native token, ADAO. The core service enables users to earn passive rewards by holding and staking the ADAO token, which increases earning potential based on the duration of staking.com is based on the staking of ADAO tokens, allowing users to earn rewards by locking their tokens on the platform. Transactions occur directly between the company and its clients, promoting a direct-to-consumer approach.Proteologics plans to develop new features and enhancements to its platform, although specific products and release dates are not detailed. The company aims to expand into additional markets in Asia and Europe by 2024. The most recent deal in January 2010 marked a strategic moment for the company as it positioned itself for future growth.
Who invested in Proteologics
3 investors across 1 round
See all investors in Proteologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 1, 2001
Amount
$14M
Investors
Questions about Proteologics
Who invested in Proteologics?
Proteologics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proteologics raised?
Proteologics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proteologics last raise money?
Proteologics's most recent round on record is a Series A, in Mar 2001.
What does Proteologics do?
Proteologics is a digital asset management company headquartered in Rehovot, Israel.
Where is Proteologics headquartered?
Proteologics is headquartered in Rehovot, Israel.
Which VCs invest in companies like Proteologics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Proteologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Proteologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.